N.L. Ogihara

757 total citations
7 papers, 621 citations indexed

About

N.L. Ogihara is a scholar working on Molecular Biology, Materials Chemistry and Inorganic Chemistry. According to data from OpenAlex, N.L. Ogihara has authored 7 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Materials Chemistry and 2 papers in Inorganic Chemistry. Recurrent topics in N.L. Ogihara's work include Protein Structure and Dynamics (3 papers), Enzyme Structure and Function (3 papers) and Metal-Catalyzed Oxygenation Mechanisms (2 papers). N.L. Ogihara is often cited by papers focused on Protein Structure and Dynamics (3 papers), Enzyme Structure and Function (3 papers) and Metal-Catalyzed Oxygenation Mechanisms (2 papers). N.L. Ogihara collaborates with scholars based in United States and Germany. N.L. Ogihara's co-authors include David Eisenberg, M.S. Weiss, William F. DeGrado, Joan Selverstone Valentine, Aram M. Nersissian, Melinda Balbirnie, Giovanna Ghirlanda, James W. Bryson, Mari Gingery and James A. Roe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Journal of Molecular Biology.

In The Last Decade

N.L. Ogihara

7 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N.L. Ogihara United States 6 353 142 137 102 85 7 621
Shabbir Ahmad United States 13 399 1.1× 118 0.8× 147 1.1× 51 0.5× 136 1.6× 20 665
Francesca Polizio Italy 17 444 1.3× 147 1.0× 163 1.2× 24 0.2× 54 0.6× 43 874
C.K. Bruns United States 5 193 0.5× 53 0.4× 197 1.4× 34 0.3× 123 1.4× 5 621
Marianne M. Lee Hong Kong 14 444 1.3× 170 1.2× 104 0.8× 31 0.3× 80 0.9× 29 689
John A. Broadwater United States 14 611 1.7× 181 1.3× 294 2.1× 20 0.2× 75 0.9× 16 892
Xue Dong China 18 681 1.9× 209 1.5× 77 0.6× 61 0.6× 16 0.2× 41 1.2k
Michael DiDonato United States 12 325 0.9× 81 0.6× 57 0.4× 32 0.3× 202 2.4× 20 889
Karin Regnström Sweden 12 683 1.9× 156 1.1× 441 3.2× 22 0.2× 244 2.9× 19 1.1k
Nathan A. Sieracki United States 8 471 1.3× 169 1.2× 222 1.6× 41 0.4× 129 1.5× 9 900
François Dolé France 12 257 0.7× 148 1.0× 136 1.0× 21 0.2× 38 0.4× 21 618

Countries citing papers authored by N.L. Ogihara

Since Specialization
Citations

This map shows the geographic impact of N.L. Ogihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N.L. Ogihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N.L. Ogihara more than expected).

Fields of papers citing papers by N.L. Ogihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N.L. Ogihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N.L. Ogihara. The network helps show where N.L. Ogihara may publish in the future.

Co-authorship network of co-authors of N.L. Ogihara

This figure shows the co-authorship network connecting the top 25 collaborators of N.L. Ogihara. A scholar is included among the top collaborators of N.L. Ogihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N.L. Ogihara. N.L. Ogihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Ma, Weijie, Shuai Chen, N.L. Ogihara, et al.. (2022). A first-in-human, phase I, open-label study of a novel cancer vaccine labvax 3(22)-23 and adjuvant GM-CSF in patients with advanced stage adenocarcinomas.. Journal of Clinical Oncology. 40(16_suppl). TPS2700–TPS2700. 1 indexed citations
2.
Ghirlanda, Giovanna, James D. Lear, N.L. Ogihara, David Eisenberg, & William F. DeGrado. (2002). A Hierarchic Approach to the Design of Hexameric Helical Barrels. Journal of Molecular Biology. 319(1). 243–253. 28 indexed citations
3.
Ogihara, N.L., Giovanna Ghirlanda, James W. Bryson, et al.. (2001). Design of three-dimensional domain-swapped dimers and fibrous oligomers. Proceedings of the National Academy of Sciences. 98(4). 1404–1409. 142 indexed citations
4.
Balbirnie, Melinda, N.L. Ogihara, Aram M. Nersissian, et al.. (1999). A Structure-Based Mechanism for Copper−Zinc Superoxide Dismutase,. Biochemistry. 38(7). 2167–2178. 218 indexed citations
5.
Ogihara, N.L., M.S. Weiss, David Eisenberg, & William F. DeGrado. (1997). The crystal structure of the designed trimeric coiled coil coil‐VaLd: Implications for engineering crystals and supramolecular assemblies. Protein Science. 6(1). 80–88. 128 indexed citations
6.
Betz, Stephen F., Daniel P. Raleigh, William F. DeGrado, et al.. (1996). Crystallization of a designed peptide from a molten globule ensemble. PubMed. 1(1). 57–64. 25 indexed citations
7.
Ogihara, N.L., Hans E. Parge, P. John Hart, et al.. (1996). Unusual Trigonal-Planar Copper Configuration Revealed in the Atomic Structure of Yeast Copper−Zinc Superoxide Dismutase,. Biochemistry. 35(7). 2316–2321. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026